If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 125,481,525 Ordinary Shares outstanding as of December 10, 2024, as disclosed in the Issuer's Form 6-K filed with the Securities and Exchange Commission (the ''SEC'') on December 10, 2024.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 125,481,525 Ordinary Shares, outstanding as of December 10, 2024, as disclosed in the Issuer's Form 6-K filed with the SEC on December 10, 2024.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 125,481,525 Ordinary Shares, outstanding as of December 10, 2024, as disclosed in the Issuer's Form 6-K filed with the SEC on December 10, 2024.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 125,481,525 Ordinary Shares, outstanding as of December 10, 2024, as disclosed in the Issuer's Form 6-K filed with the SEC on December 10, 2024.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 125,481,525 Ordinary Shares, outstanding as of December 10, 2024, as disclosed in the Issuer's Form 6-K filed with the SEC on December 10, 2024.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 125,481,525 Ordinary Shares, outstanding as of December 10, 2024, as disclosed in the Issuer's Form 6-K filed with the SEC on December 10, 2024.


SCHEDULE 13D




Comment for Type of Reporting Person:
Calculated based on 125,481,525 Ordinary Shares, outstanding as of December 10, 2024, as disclosed in the Issuer's Form 6-K filed with the SEC on December 10, 2024.


SCHEDULE 13D






SCHEDULE 13D


 
Oaktree Value Opportunities Fund, L.P.
 
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Authorized Signatory
Date:12/18/2024
 
Oaktree London Liquid Value Opportunities Fund (VOF), L.P.
 
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Authorized Signatory
Date:12/18/2024
 
Oaktree Phoenix Investment Fund, L.P.
 
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Authorized Signatory
Date:12/18/2024
 
Oaktree Capital Management, L.P.
 
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Authorized Signatory
Date:12/18/2024
 
Oaktree Fund GP I, L.P.
 
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Authorized Signatory
Date:12/18/2024
 
Oaktree Capital Holdings, LLC
 
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Authorized Signatory
Date:12/18/2024
 
Oaktree Capital Group Holdings GP, LLC
 
Signature:/s/ Henry Orren
Name/Title:Henry Orren / Authorized Signatory
Date:12/18/2024
 
Brookfield Asset Management ULC
 
Signature:/s/ Kathy Sarpash
Name/Title:Kathy Sarpash / Managing Director, Legal & Regulatory
Date:12/18/2024